References
Gao B, Lyu C, Lerner A, McKinney AM (2018) Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatry 89:14–20. https://doi.org/10.1136/jnnp-2017-316225
Sorensen CG, Karlsson WK, Amin FM, Lindelof M (2020) Metronidazole-induced encephalopathy: a systematic review. J Neurol 267:1–13. https://doi.org/10.1007/s00415-018-9147-6
Kikuchi S, Orii F, Maemoto A, Ashida T (2016) Reversible posterior leukoencephalopathy syndrome associated with treatment for acute exacerbation of ulcerative colitis. Intern Med 55:473–477. https://doi.org/10.2169/internalmedicine.55.5250
Hobson-Webb LD, Roach ES, Donofrio PD (2006) Metronidazole: newly recognized cause of autonomic neuropathy. J Child Neurol 21:429–431. https://doi.org/10.1177/08830738060210051201
Velickovic-Radovanovic R, Catic-Dordevic A, Dinic K, Radivojevic J, Zikic O, Cvetkovic T, Mitic B (2019) Metronidazole- and levofloxacin-induced psychotic disorders in chronic kidney patient. Eur J Hosp Pharm 26:347–349. https://doi.org/10.1136/ejhpharm-2018-001677
Funding
This work was supported by grants from Chikusei City.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hosaka, T., Terada, M., Okubo, K. et al. Management of a rare case of metronidazole-induced encephalopathy presenting as posterior reversible encephalopathy syndrome: a case report. Neurol Sci 44, 1101–1103 (2023). https://doi.org/10.1007/s10072-022-06480-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06480-3